S2Medical Valuation
| S2M Stock | SEK 0.01 0.0002 1.43% |
S2Medical seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of S2Medical AB from reviewing the entity fundamentals such as Shares Outstanding of 29.37 M, return on asset of -0.68, and Return On Equity of -1.93 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that S2Medical's price fluctuation is out of control at this time. Calculation of the real value of S2Medical AB is based on 3 months time horizon. Increasing S2Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
S2Medical's intrinsic value may or may not be the same as its current market price of 0.01, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0142 | Real 0.0127 | Hype 0.01 |
The intrinsic value of S2Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence S2Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of S2Medical AB helps investors to forecast how S2Medical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of S2Medical more accurately as focusing exclusively on S2Medical's fundamentals will not take into account other important factors: S2Medical Total Value Analysis
S2Medical AB is at this time expected to have takeover price of 26.44 M with market capitalization of 24.97 M, debt of 0, and cash on hands of 32.15 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the S2Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
26.44 M | 24.97 M | 0 | 32.15 M |
S2Medical Investor Information
About 38.0% of the company outstanding shares are owned by corporate insiders. The book value of S2Medical was at this time reported as 0.34. The company recorded a loss per share of 1.57. S2Medical AB had not issued any dividends in recent years. The entity had 42:31 split on the 19th of April 2022. S2Medical AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.S2Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. S2Medical has an asset utilization ratio of 25.95 percent. This implies that the Company is making kr0.26 for each dollar of assets. An increasing asset utilization means that S2Medical AB is more efficient with each dollar of assets it utilizes for everyday operations.S2Medical Ownership Allocation
S2Medical AB shows a total of 29.37 Million outstanding shares. S2Medical AB maintains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the entity is less than the current market value, you may not be able to make money on it.S2Medical Profitability Analysis
The company reported the revenue of 7.7 M. Net Loss for the year was (20.08 M) with profit before overhead, payroll, taxes, and interest of 7.42 M.About S2Medical Valuation
The stock valuation mechanism determines S2Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of S2Medical AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of S2Medical. We calculate exposure to S2Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of S2Medical's related companies.S2Medical AB develops, produces, and sells wound healing products for burns and chronic wounds. The company was founded in 2013 and is headquartered in Linkping, Sweden. S2Medical is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct S2Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates S2Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct S2Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain S2Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine S2Medical's revenue streams: Identify S2Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research S2Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish S2Medical's growth potential: Evaluate S2Medical's management, business model, and growth potential.
- Determine S2Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate S2Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for S2Medical Stock Analysis
When running S2Medical's price analysis, check to measure S2Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy S2Medical is operating at the current time. Most of S2Medical's value examination focuses on studying past and present price action to predict the probability of S2Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move S2Medical's price. Additionally, you may evaluate how the addition of S2Medical to your portfolios can decrease your overall portfolio volatility.